Circulatory shock is a life-threatening disease that accounts for around one-third of all admissions to intensive care units (ICU). It requires immediate treatment, which is why the development of tools for planning therapeutic interventions is required to deal with shock in the critical care environment. In this study, the ShockOmics European project original database is used to extract attributes capable of predicting mortality due to shock in the ICU. Missing data imputation techniques and machine learning models were used, followed by feature selection from different data subsets. Selected features were later used to build Bayesian Networks, revealing causal relationships between features and ICU outcome. The main result is a subset of ...
The Society for Cardiovascular Angiography and Interventions (SCAI) Shock Classification was develop...
We studied the problem of mortality prediction in two datasets, the first composed of 23 septic shoc...
BackgroundThe ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospect...
Circulatory shock is a life-threatening disease that accounts for around one-third of all admissions...
Circulatory shock is a life-threatening disease that accounts for around one-third of all admissions...
Septic Shock is a critical pathological state that affects patients entering the intensive care unit...
This work attempts to identify biomarkers that can be used as indicators for mortality prediction in...
Sepsis remains the second largest killer in the Intensive Care Unit (ICU), giving rise to a signific...
Introduction: Recent advances in machine learning provide new possibilities to process and analyse o...
Sepsis is caused by the dysregulated host response to infection and potentially is the main cause of...
Background Mortality prediction in critically ill patients with cardiogenic shock can guide triage a...
In the intensive care unit, patients with crucial, life-threatening conditions are admitted and need...
Background: The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospe...
Background: Sepsis is a life-threatening clinical condition that happens when the patient’s body has...
Sepsis is a life-threatening condition due to the reaction to an infection. With certain changes in ...
The Society for Cardiovascular Angiography and Interventions (SCAI) Shock Classification was develop...
We studied the problem of mortality prediction in two datasets, the first composed of 23 septic shoc...
BackgroundThe ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospect...
Circulatory shock is a life-threatening disease that accounts for around one-third of all admissions...
Circulatory shock is a life-threatening disease that accounts for around one-third of all admissions...
Septic Shock is a critical pathological state that affects patients entering the intensive care unit...
This work attempts to identify biomarkers that can be used as indicators for mortality prediction in...
Sepsis remains the second largest killer in the Intensive Care Unit (ICU), giving rise to a signific...
Introduction: Recent advances in machine learning provide new possibilities to process and analyse o...
Sepsis is caused by the dysregulated host response to infection and potentially is the main cause of...
Background Mortality prediction in critically ill patients with cardiogenic shock can guide triage a...
In the intensive care unit, patients with crucial, life-threatening conditions are admitted and need...
Background: The ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospe...
Background: Sepsis is a life-threatening clinical condition that happens when the patient’s body has...
Sepsis is a life-threatening condition due to the reaction to an infection. With certain changes in ...
The Society for Cardiovascular Angiography and Interventions (SCAI) Shock Classification was develop...
We studied the problem of mortality prediction in two datasets, the first composed of 23 septic shoc...
BackgroundThe ShockOmics study (ClinicalTrials.gov identifier NCT02141607) is a multicenter prospect...